Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil and Prednisone in Membranous Nephropathy
NCT00135967Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of mycophenolate mofetil in membranous nephropathy (MN), sponsored by Radboud University Medical Center. Primary endpoints: Renal Function (Serum Creatinine) and Proteinuria. Started May 2002; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
membranous nephropathy (MN)
Beyond the preview
Go deeper on NCT00135967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135967.